Evolent Health, Inc. (EVH)
4.22
-0.01
(-0.24%)
USD |
NYSE |
Sep 03, 11:37
Evolent Health Free Cash Flow : 24.34M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.34M |
| March 31, 2026 | 1.395M |
| December 31, 2025 | 4.755M |
| September 30, 2025 | -68.67M |
| June 30, 2025 | -63.14M |
| March 31, 2025 | -9.72M |
| December 31, 2024 | -6.128M |
| September 30, 2024 | 109.58M |
| June 30, 2024 | 150.93M |
| March 31, 2024 | 130.43M |
| December 31, 2023 | 113.84M |
| September 30, 2023 | 55.46M |
| June 30, 2023 | -11.61M |
| March 31, 2023 | -0.993M |
| December 31, 2022 | -49.91M |
| September 30, 2022 | -15.45M |
| June 30, 2022 | 36.16M |
| March 31, 2022 | 1.918M |
| December 31, 2021 | 13.76M |
| September 30, 2021 | -64.36M |
| June 30, 2021 | -129.29M |
| March 31, 2021 | -71.86M |
| December 31, 2020 | -47.98M |
| September 30, 2020 | -24.64M |
| Date | Value |
|---|---|
| June 30, 2020 | -23.21M |
| March 31, 2020 | -72.63M |
| December 31, 2019 | -78.18M |
| September 30, 2019 | -118.22M |
| June 30, 2019 | -79.54M |
| March 31, 2019 | -61.72M |
| December 31, 2018 | -60.20M |
| September 30, 2018 | -25.26M |
| June 30, 2018 | -43.81M |
| March 31, 2018 | -49.32M |
| December 31, 2017 | -55.81M |
| September 30, 2017 | -81.26M |
| June 30, 2017 | -72.10M |
| March 31, 2017 | -67.62M |
| December 31, 2016 | -51.04M |
| September 30, 2016 | -34.04M |
| June 30, 2016 | -47.34M |
| March 31, 2016 | -49.14M |
| December 31, 2015 | -24.98M |
| September 30, 2015 | -16.06M |
| June 30, 2015 | -6.823M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DarioHealth Corp. | -25.48M |
| CompuMed, Inc. | 0.5219M |
| Teladoc Health, Inc. | 114.02M |
| Renalytix Plc | -- |
| Lifestance Health Group, Inc. | 173.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.312M |
| Cash from Investing (Quarterly) | -6.699M |
| Cash from Financing (Quarterly) | -10.99M |
| Free Cash Flow Per Share (Quarterly) | -0.1436 |
| Free Cash Flow to Equity (Quarterly) | -1.17M |
| Free Cash Flow to Firm (Quarterly) | 2.483M |
| Free Cash Flow Yield | 5.13% |